Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Adrian Wildfire

Adrian Wildfire

Adrian Wildfire has worked as an infectious disease specialist for over 30 years, having trained and worked within the fields of bacteriology, virology, parasitology and mycology after obtaining his Fellowship in Medical Microbiology in 1990, and a Masters in Parasitology in 1998. He has specialised in Human Challenge Models for nearly 10 years and is currently leading a multidisciplinary team manufacturing challenge agents for use in clinical trials. He is the author of numerous published papers and articles relating to HIV, ethics and viral challenge amongst others.

  • Contributions

The Winning Formula

June 13, 2018

Meet the three frontrunners of The Medicine Maker 2017 Innovation Awards – spanning influenza vaccine development, a virtual reality space, and a way to boost monoclonal antibody manufacturing. Is there a recipe for success?

1 min read

The Winning Formula

The Human Challenge

February 22, 2017

We need to get better at predicting the real-world efficacy of vaccines. Human challenge studies are one possible way of achieving this.

1 min read

The Human Challenge

The Pandemic Diaries

May 19, 2020

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

1 min read

The Pandemic Diaries

Failing Safely: Why Ending Some Programmes Early May Be a Recipe for Successes Later

February 27, 2020

With so much time and money invested into pre-clinical research and early phase clinical trials, why are compounds still failing at the final hurdle?

1 min read

Failing Safely: Why Ending Some Programmes Early May Be a Recipe for Successes Later

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.